RxDoctor Payments Data

Laura Kissell, MD

Vascular Surgery · Colorado Springs, CONPI 1730130337

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Endologix LLC at 27.4% of the total. Reporting peaked in 2019 at $443 and has fallen 73.2% since, to $119 in 2025. That places this record below the midpoint for vascular surgery clinicians in CO, where the typical reported total is $4,981.

$2,116in general payments, 2019–2025

Across 32 payments — averaging $66.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$580
  • W. L. Gore & Associates, Inc.$462
  • Cook Medical LLC$318
  • Bolton Medical Inc$242
  • Penumbra, Inc.$139
  • Sanofi-aventis U.S. LLC$125
  • plus $250 from 5 others

What the payments were for

  • Food & beverage$2,116100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,116 in reported general payments places this provider in the 30th percentile of 66 vascular surgery providers in Colorado.

See all vascular surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$210,846
Medicare patients
703
Services billed
1,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$27,418
XareltoRivaroxaban24$24,800
BrilintaTicagrelor13$6,742
ClopidogrelClopidogrel Bisulfate107$1,325
Atorvastatin Calcium95$684
Cilostazol28$679
Pantoprazole Sodium12$84

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →